Increased expression of inducible nitric oxide synthase (iNOS) in N-nitrosobis(2-oxopropyl)amine-induced hamster pancreatic carcinogenesis and prevention of cancer development by ONO-1714, an iNOS inhibitor

Carcinogenesis

Volumn 29, Issue 8, 2008, Pages 1608-1613

  Takahashi, Mami ^a   Kitahashi, Tsukasa ^a   Ishigamori, Rikako ^a   Mutoh, Michihiro ^a   Komiya, Masami ^a   Sato, Hidetaka ^b   Kamanaka, Yoshihisa ^c   Naka, Masao ^c   Maruyama, Takayuki ^c   Sugimura, Takashi ^a   Wakabayashi, Keiji ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b JAPAN FOOD RESEARCH LABORATORIES   (Japan)

^c ONO PHARMACEUTICAL CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

7 CHLORO 3 IMINO 5 METHYL 2 AZABICYCLO[4.1.0]HEPTANE; BIS(2 OXOPROPYL)NITROSAMINE; INDUCIBLE NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE INHIBITOR; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CANCER PREVENTION; CARCINOGENESIS; CONTROLLED STUDY; DRUG DOSE COMPARISON; FEMALE; HAMSTER; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MACROPHAGE; NONHUMAN; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREAS ISLET CELL; PANCREAS ISLET CELL HYPERPLASIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR REGRESSION;

AMIDINES; ANIMALS; CARCINOGENS; CELL LINE, TUMOR; CRICETINAE; DNA PRIMERS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HETEROCYCLIC COMPOUNDS, 2-RING; HUMANS; MESOCRICETUS; NITRIC OXIDE SYNTHASE TYPE II; NITROSAMINES; PANCREATIC NEOPLASMS; RNA, MESSENGER;

EID: 49649100910     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgn152     Document Type: Article

References (50)

1. Parkin,D.M. et al. (2001) Estimating the world cancer burden: Globocan 2000. Int. J. Cancer, 94, 153-156.
2. Farrow,B. et al. (2002) Inflammation and the development of pancreatic cancer. Surg. Oncol., 10, 153-169.
3. Michaud,D.S. (2004) Epidemiology of pancreatic cancer. Minerva. Chir. 59, 99-111.
4. Otsuki,M. et al. (2007) 4. Chronic pancreatitis and pancreatic cancer, lifestyle-related diseases. Intern. Intern. Med., 46 109-113.
5. Kemppainen,E. et al. (2007) Non-alcoholic etiologies of acute pancreatitis - exclusion of other etiologic factors besides alcohol and gallstones. Pancreatology, 7, 142-146.
6. Hussain,S.P. et al. (2007) Inflammation and cancer: An ancient link with novel potentials. Int. J. Cancer, 121, 2373-2380.
7. Vickers,S.M. et al. (1999) Association of increased immunostaining for inducible nitric oxide synthase and nitrotyrosine with fibroblast growth factor transformation in pancreatic cancer. Arch. Suurg., 134, 245-251.
8. Kong,G. et al. (2001) Inducible nitric oxide synthase (iNOS) immunoreactivity and its relationship to cell proliferation, apoptosis, angiogenesis, clinicopathologic characteristics, and patient survival in pancreatic cancer. Int. J. Pancreatol., 29, 133-140.
9. Kong,G. et al. (2002) Role of cyclooxygenase-2 and inducible nitric oxide synthase in pancreatic cancer. J. Gastroenterol. Hepatol., 17, 914-921.
10. Al-Mufti,R.A. et al. (1998) Increased nitric oxide activity in a rat model of acute pancreatitis. Gut, 43, 564-570.
11. Mikawa,K. et al. (2001) ONO-1714, a new inducible nitric oxide synthase inhibitor, attenuates diaphragmatic dysfunction associated with cerulein-induced pancreatitis in rats. Crit. Care Med., 29, 1215-1221.
12. Sandstrom,P. et al. (2005) Highly selective inhibition of inducible nitric oxide synthase ameliorates experimental acute pancreatitis. Pancreas, 30, e10-e15.
13. Naka,M. et al. (2000) A potent inhibitor of inducible nitric oxide synthase, ONO-1714, a cyclic amidine derivative. Biochem. Biophys. Res. Commun., 270, 663-667.
14. Hayashi,Y. et al. (2005) Comparison of effects of nitric oxide synthase (NOS) inhibitors on plasma nitrite/nitrate levels and tissue NOS activity in septic organs. Microbiol. Immunol., 49, 139-147.
15. Asp12 cDNA markedly elevates IL-1β and lipopolysaccharide-mediated inducible nitric oxide synthase expression in rat intestinal epithelial cells. Oncogene, 22, 7667-7676.
16. Takahashi,M. et al. (2006) Suppressive effect of an inducible nitric oxide inhibitor, ONO-1714, on AOM-induced rat colon carcinogenesis. Nitric Oxide, 14, 130-136.
17. Kohno,H. et al. (2007) A specitic nitric oxide synthase inhibitor, ONO-1714 attenuates inflammation-related large bowel carcinogenesis in male Apc(Min/+) mice. Int. J. Cancer, 121, 506-513.
18. Pour,P. et al. (1977) A potent pancreatic carcinogen in Syrian hamsters: N-nitrosobis(2-oxopropyl)amine. J. Natl Cancer Inst. 58, 1449-1453.
19. Fujii,H. et al. (1991) Pancreatic ductal adenocarcinomas induced in Syrian hamsters by N-nitrosobis(2-oxopropyl)amine contain a c-Ki-ras oncogene with a point-mutated codon 12. Mol. Carcinog., 3, 296-301.
20. Tsujiuchi,T. et al. (2003) Alterations in the Fhit gene in pancreatic duct adenocarcinomas induced by N nitosobis(2-oxopropyl)amine in hamsters. Mol. Carcinog., 36 60-66.
21. Grunewald,K. et al. (1989) High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinomas. Int. J. Cancer, 43, 1037-1041.
22. Sorio,C. et al. (1999) The FHIT gene is expressed in pancreatic ductular cells and is altered in pancreatic cancers. Cancer Res., 59, 1308-1314.
23. Crowell,P.L. et al. (2006) Cyclooxygenase-2 expression in hamster and human pancreatic neoplasia. Neoplasia, 8, 437-445.
24. Saito,S. et al. (1988) Establishment and characterization of a cultured cell line derived from nitrosamine-induced pancreatic ductal adenocarcinoma in Syrian golden hamsters. Gastroenterol. Jpn., 23, 183-194.
25. Furukawa,T. et al. (1996) Long-term culture and immortalization of epithelial cells from normal adult human pancreatic duets transfected by the E6E7 gene of human papilloma virus 16. Am. J. Pathol., 148 1763-1770.
26. Takeuchi,Y. et al. (2007) Suppression of N nitrosobis(2-oxopropyl)amine-induced pancreutic carcinogenesis in hamsters by pioglitazone, a ligand of peroxisome proliterator-activated receptor gamma. Carcinogenesis, 28, 1692-1696.
27. Takahashi,M. et al. (1997) Increased expression of inducible and endothelial constitutive nitric oxide synthases in rat colon tumors induced by azoxymethane. Cancer Res., 57, 1233-1237.
28. Folkman,J. (1990) What is the evidence that tumors are angiogenesis dependent? J. Natl Cancer Inst., 82, 4-6.
29. Wu,J. et al. (2001) Enhanced vascular permeability in solid tumor involving peroxynitrite and matrix metalloproteinases. Jpn. J. Cancer Res, 92, 439-451.
30. Cerny, W.L. et al. (1992) K-ras mutation is an early event in pancreatic duct carcinogenesis in the Syrian golden hamster. Cancer Res., 52, 4507-4513.
31. Mu,D.Q. et al. (2004) Values of mutations of K-ras oncogene at codon 12 in detection of pancreatic cancer: 15-year experience. World J. Gastroenterol., 10, 471-475.
32. Burmer,G.C. et al. (1991) Frequency and spectrum of c-Ki-ras mutations in human sporadic colon carcinoma, carcinomas arising in ulcerative colitis, and pancreatic adenocarcinoma. Environ. Health Perspect., 93, 27-31.
33. Minamoto,T. et al. (2000) K-ras mutation: Early detection in molecular diagnosis and risk assessment of colorectal, pancreas, and lung cancers - a review. Cancer Detect. Prev., 24, 1-12.
34. Acalovschi,M. (2004) Cholangiocarcinoma: Risk factors, diagnosis and management. Rom. J. Intern. Med., 42, 41-58.
35. Ambs,S. et al. (1998) Frequent nitric oxide synthase-2 expression in human colon adenomas: Implication for tumor angiogenesis and colon cancer progression. Cancer Res., 58, 334-341.
36. Liu,C.-Y. et al. (1998) Increased level of exhaled nitric oxide and upregulation of inducible nitric oxide synthase in patients with primary lung cancer. Br. J. Cancer, 78, 534-541.
37. Pinlaor,S. et al. (2005) Nitrative and oxidative DNA damage in intrahepatic cholangiocarcinoma patients in relation to tumor invasion. World J. Gastroenterol., 11, 4644-4649.
38. Yamanaka,S. et al. (1997) K-ras gene mutations in intrahepatic bile duct of Syrian golden hamsters. J. Surg. Oncol., 66, 97-103.
39. Takahashi,M. et al. (2000) Altered expression of β-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis. Carcinogenesis, 21, 1319-1327.
40. Kwon,G. et al. (1995) Interleukin-1 beta-induced nitric oxide synthase expression by rat pancreatic beta-cells: Evidence for the involvement of nuclear factor kappa B in the signaling mechanism. Endocrinology, 136, 4790-4795.
41. McDaniel,M.L. et al. (1996) Cytokines and nitric oxide in islet inflammation and diabetes. Proc. Soc. Exp. Biol. Med., 211, 24-32.
42. Kitahashi,T. et al. (2004) Aberrant transcription of FIIIT gene in intrahepatic cholangiocellular carcinomas induced by N nitrosobis(2-oxopropyl)amine in hamsters. Exp. Toxicol. Pathol. 56, 153-157
43. Sharma,S. et al. (2002) Differential activity of NO synthase inhibitors as chemopreventive agents in a primary rat tracheal epithelial cell transformation system. Neoplasia, 4, 332-336.
44. Kisley,L.R. et al. (2002) Genetic ablation of inducible nitric oxide synthase decreases mouse lung tumorigenesis. Cancer Res., 62, 6850-6856.
45. Puhakka,A. et al. (2003) High expression of nitric oxide synthases is a favorable prognostic sign in non-small cell lung carcinoma. APMIS, 111, 1137-1146.
46. Son,H.-Y. et al. (2000) Modifying effects of 4-phenylbutyl isothiocyanate on N-nitrosobis(2-oxopropyl)amine-induced tumorigenesis in hamsters. Cancer Lett., 160, 141-147.
47. Nishikawa,A. et al. (1996) Chemopreventive effects of phenethyl isothiocyanate on lung and pancreatic tumorigenesis in N nitrosobis(2-oxopropyl)amine-treated hamsters. Carcinogenesis, 17, 1381-1384.
48. Furukawa,F. et al. (2003) A cyclooxygenase-2 inhibitor, nimesulide, inhibits postinitiation phase of N nitrosobis(2-oxopropyl)amine-induced pancreatic carcinogenesis in hamsters. Int. J. Cancer, 104, 269-273.
49. Beauregard,C. et al. (2003) Peroxisome proliferator-activated receptor agonists inhibit interleukin-1beta-mediated nitric oxide production in cultured lacrimal gland acinar cells. J. Ocul. Pharmacol. Ther., 19, 579-587.
50. Crosby,M.B. et al. (2005) A novel PPAR response element in the murine iNOS promoter. Mol. Immunol., 42, 1303-1310.